RVRussell E. Vance

Russell E. Vance

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Recognitions

Top Cited Scholar (2025)

Russell E. Vance has a total of 370 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diverse infection models demonstrate robust resistance of Mycobacterium tuberculosis to innate immunity

    by Marian R. Fairgrieve, Ella C. Brydon, Roberto A. Chavez, Dmitri I. Kotov, Russell E. Vance

    Mycobacterium tuberculosis (Mtb) is a robust activator of innate immunity. While innate immune activation of macrophages can impact Mtb replication in vitro , there is little in vivo evidence that the innate immune system controls Mtb before the onset of adaptive immunity. Prior work has generally used specific pathogen-free (SPF) mouse models and relatively large infectious doses, which may obscure the capacity of innate immunity to control Mtb. Here, we performed ultra-low dose Mtb infections and found that the initial innate immune response was unable to curb even minimal Mtb infectious doses. Additionally, we primed the immune systems of C57BL/6 mice by co-housing with “pet shop” mice prior to Mtb exposure. Co-housed mice were as susceptible to Mtb infection as SPF mice. To pre-activate innate immunity at the site of Mtb infection more specifically, we also infected the lungs of mice with Legionella pneumophila (Lp) prior to Mtb. Innate immunity alone can clear large doses (>100,000 CFU) of Lp from the lung within a few days. However, priming the mouse lung by pre-infection with Lp only modestly reduced Mtb CFU compared to mice infected with only Mtb, indicating that Mtb can robustly replicate even in the presence of a strong anti-bacterial innate response. We performed single-cell RNA-sequencing on myeloid cells from mice either infected with Mtb alone or mice primed with Lp. We found that Lp priming before Mtb infection induced measurable changes in myeloid cells responding to Mtb, but these changes had little effect on innate control of Mtb. Together, these data demonstrate the robust resistance of Mtb to innate immune clearance under diverse experimental conditions.

  • Open Access

    Mechanisms of mucosal immunity to oral Shigella infection in a physiological mouse model

    by Janet Peace Babirye, Emma F. Lackner, Sudyut Yuvaraj, Roberto A. Chavez, Charlotte A. Nichols, Kevin D. Eislmayr, Stefan A. Fattinger, Dmitri I. Kotov, Cammie F. Lesser, Russell E. Vance

    Shigella flexneri causes bacillary dysentery, a diarrheal disease responsible for significant global morbidity and mortality. Despite extensive efforts, there is no licensed Shigella vaccine, and due to the lack of tractable and physiological models, mechanisms of adaptive immunity to Shigella are poorly understood. Here, we establish a mouse model that permits mechanistic dissection of adaptive immunity to a physiological oral challenge with Shigella . We find primary Shigella infection confers robust cross-serotype protection against secondary challenge, in a manner strictly dependent on the adaptive immune compartment. Shigella infection induces Shigella -specific CD4 + and CD8 + T cells, but only CD4 + T cells are required for protection. CD4 + T cells produce IFN γ upon secondary challenge, and help B cells produce Shigella -specific IgA. Neither anti- Shigella antibodies nor IFN γ are individually required for immunity to Shigella , but loss of both eliminates protective immunity. Collectively, our results demonstrate that CD4 + T cells orchestrate antibody and cytokine defense against shigellosis.

  • Open Access

    Strong, sustained type I IFN signaling acts cell intrinsically to impair IFNγ responses and cause tuberculosis susceptibility

    by Stefan A. Fattinger, Bianca Parisi, Roberto A. Chavez, Marian R. Fairgrieve, Ophelia V. Lee, Kristen C. Witt, Jesse J. Rodriguez, Elizabeth A. Turcotte, Ella C. Brydon, Harmandeep Dhaliwal, et al.


  • Poxvirus attack of antiviral defense pathways unleashes an effector-triggered NF-κB response

    by Brenna C. Remick, Joshua Q. Mao, Andrew G. Manford, Ami D. Gutierrez-Jensen, Allon Wagner, Michael Rape, Grant McFadden, Masmudur M. Rahman, Moritz M. Gaidt, Russell E. Vance

    Effector-triggered immunity (ETI) is a form of pathogen sensing that involves detection of pathogen-encoded virulence factors or “effectors.” To discover ETI pathways in mammals, we developed a screening approach in which we expressed individual virulence factors in a human monocyte cell line and assessed transcriptional responses by RNA sequencing. We identified a poxvirus effector, myxoma virus M3.1, which elicited an antiviral nuclear factor κB (NF-κB) response. NF-κB was unleashed by an ETI pathway that sensed M3.1 attack of two antiviral complexes: zinc finger antiviral protein and TBK1. NF-κΒ activation occurred because the proteins inhibited by M3.1—N4BP1, ZC3H12A, and TBK1—are negative regulators of NF-κB. Our study established a systematic approach for the discovery of ETI pathways, and the results illustrated how negative regulators of immune responses may function in pathogen sensing.


  • Open Access

    Strong sustained type I IFN signaling acts cell intrinsically to impair IFNγ responses and cause tuberculosis susceptibility

    by Stefan A Fattinger, Roberto A Chavez, Kristen C Witt, Bianca Parisi, Jesse J Rodriguez, Elizabeth A Turcotte, Ella C Brydon, Marian R Fairgrieve, Harmandeep Dhaliwal, Angus Y Lee, et al.

    Mycobacterium tuberculosis ( Mtb ) causes over one million deaths annually, but most infected individuals never exhibit symptoms. Type I interferons (IFNs) have emerged as a major factor driving susceptibility to Mtb , but how type I IFNs impair immunity to Mtb is a key unresolved question. Here we show that an early effect of type I IFN during Mtb infection is the cell-intrinsic impairment of IFNγ signaling. IFNγ signaling was selectively impaired in the subset of infected macrophages experiencing high and sustained levels of type I IFN signaling. Genetic elimination of RESIST, a recently described positive regulator of type I IFN production, specifically eliminated the high and sustained type I IFN response, fully restored IFNγ signaling, and rescued susceptibility to Mtb without affecting basal type I IFN responses. Our results demonstrate that strong and sustained type I IFN responses specifically and cell intrinsically impair responsiveness to IFNγ to cause susceptibility to Mtb .


  • Open Access

    Shigella OspF blocks rapid p38-dependent priming of the NAIP–NLRC4 inflammasome

    by Elizabeth A. Turcotte, Kyungsub Kim, Kevin D. Eislmayr, Lisa Goers, Patrick S. Mitchell, Cammie F. Lesser, Russell E. Vance

    The NAIP–NLRC4 inflammasome senses pathogenic bacteria by recognizing the cytosolic presence of bacterial proteins such as flagellin and type III secretion system (T3SS) subunits. In mice, the NAIP–NLRC4 inflammasome provides robust protection against bacterial pathogens that infect intestinal epithelial cells, including the gastrointestinal pathogen Shigella flexneri . By contrast, humans are highly susceptible to Shigella , despite the ability of human NAIP–NLRC4 to robustly detect Shigella T3SS proteins. Why the NAIP–NLRC4 inflammasome protects mice but not humans against Shigella infection remains unclear. We previously found that human THP-1 cells infected with Shigella lose responsiveness to NAIP–NLRC4 stimuli, while retaining sensitivity to other inflammasome agonists. Using mT3Sf, a “minimal Shigella ” system, to express individual secreted Shigella effector proteins, we found that the OspF effector specifically suppresses NAIP–NLRC4-dependent cell death during infection. OspF was previously characterized as a phosphothreonine lyase that inactivates p38 and ERK MAP kinases. We found that p38 was critical for rapid priming of NAIP–NLRC4 activity, particularly in cells with low NAIP–NLRC4 expression. Overall, our results provide a mechanism by which Shigella evades inflammasome activation in humans, and describe a mechanism for rapid priming of the NAIP–NLRC4 inflammasome.


  • Open Access

    Diverse infection models demonstrate robust resistance of Mycobacterium tuberculosis to innate immunity

    by Marian R. Fairgrieve, Ella C. Brydon, Roberto A. Chavez, Dmitri I. Kotov, Russell E. Vance

    Mycobacterium tuberculosis (Mtb) is a robust activator of innate immunity. However, there is little evidence that innate immune mechanisms control Mtb before the onset of adaptive immunity. Prior work has generally used specific pathogen-free (SPF) mouse models and relatively large infectious doses, which may obscure the capacity of innate immunity to control Mtb. Here, we performed ultra-low dose Mtb infections and found that the initial innate immune response was unable to curb even minimal Mtb infectious doses. Additionally, we primed the immune systems of C57BL/6 mice by co-housing with “pet shop” mice prior to Mtb exposure. Co-housed mice were as susceptible to Mtb infection as SPF mice. To pre-activate innate immunity at the site of Mtb infection more specifically, we also infected the lungs of mice with Legionella pneumophila (Lp) prior to Mtb. Innate immunity alone can clear large doses (>100,000 CFU) of Lp from the lung within a few days. However, priming the mouse lung by pre-infection with Lp only modestly reduced Mtb CFU compared to mice infected with only Mtb, indicating that Mtb can robustly replicate even in the presence of a strong anti-bacterial innate response. We performed single-cell RNA-sequencing on myeloid cells from mice either infected with Mtb alone or mice primed with Lp. We found that Lp priming before Mtb infection induced measurable changes in myeloid cells responding to Mtb, but these changes had little effect on innate control of Mtb. Together, these data demonstrate the robust resistance of Mtb to innate immune clearance under diverse experimental conditions.


  • Open Access

    Tuberculosis susceptibility in genetically diverse mice reveals functional diversity of neutrophils

    by Marietta M Ravesloot-Chavez, Erik Van Dis, Douglas Fox, Andrea Anaya-Sanchez, Scott Espich, Xammy Huu Nguyenla, Sagar Rawal, Helia Samani, Mallory Ballinger, Henry F Thomas, et al.

    Tuberculosis is a heterogeneous disease in humans with individuals exhibiting a wide range of susceptibility. This heterogeneity is not captured by standard laboratory mouse lines. We used a new collection of 19 wild-derived inbred mouse lines collected from diverse geographic sites to identify novel phenotypes during Mycobacterium tuberculosis (Mtb) infection. Wild-derived mice have heterogeneous immune responses to infection that result in differential ability to control disease at early time points. Correlation analysis with multiple parameters including sex, weight, and cellular immune responses in the lungs revealed that enhanced control of infection is associated with increased numbers of CD4 T cells, CD8 T cells, and B cells. Surprisingly, we did not observe strong correlations between IFN-γ production and control of infection. Although in most lines high neutrophils were associated with susceptibility, we identified a mouse line that harbors high neutrophil numbers yet controls infection. Using single-cell RNA sequencing, we identified a novel neutrophil signature associated with failure to control infection.


  • Open Access

    Infectious Disease: Evolution, Mechanism and Global Health

    by Rachel Hackett, Judith E. Allen, Sumana Sanyal, David M. Tobin, Russell Vance


  • Open Access

    Macrophages orchestrate elimination of Shigella from the intestinal epithelial cell niche via TLR-induced IL-12 and IFN-γ

    by Kevin D. Eislmayr, Charlotte A. Nichols, Fitty L. Liu, Sudyut Yuvaraj, Janet Peace Babirye, Justin L. Roncaioli, Jenna Vickery, Gregory M. Barton, Cammie F. Lesser, Russell E. Vance